Growth hormone, fatigue, poor sleep, and disability in HIV infection.
Poor sleep, daytime fatigue, and loss of cognitive ability exist during all stages of HIV infection, worsening with disease progression. These symptoms contribute to disability and poor quality of life. Data from several research groups support a role of somnogenic inflammatory process peptides elevated in HIV infection, e.g. TNF alpha. Though the literature is in conflict regarding an effect of HIV infection on growth hormone (GH) secretion, GH axis dysregulation and treatment with GH may be important in HIV infection, e.g. in the wasting syndrome. It has long been known that GH varies with changes in sleep. The hypothesis tested in the current study was that the relationship between delta frequency (0.5-4.0 Hz) sleep EEG amplitude (square root of power from frequency analysis) and GH secretion would differ between HIV positive (HIV+) and HIV negative (HIV-) subjects. In 14 subjects (6 HIV+ and 8 HIV-, none with current or past AIDS-defining illness) a linear relationship change across the night's sleep was found in the coupling between delta frequency sleep EEG amplitude and GH secretion. The phase coupling change was in opposite directions in HIV+ versus HIV- subjects. This difference supports the hypothesis that the brain-based coordination of sleep and sleep-related physiology deteriorates early in HIV infection, and that GH dysregulation may contribute to this sleep pathology.
Darko
D F
DF
Department of Neuropharmacology, Scripps Research Institute, La Jolla, Calif 92037-1027, USA. ddarko@scripps.edu
Mitler
M M
MM
Miller
J C
JC
D000328:Adult; D006233:Persons with Disabilities; D018450:Disease Progression; D004569:Electroencephalography; D005221:Fatigue / Q000503:physiopathology*; D005260:Female; D015658:HIV Infections / Q000503:physiopathology*; D019382:Human Growth Hormone / Q000378:metabolism*; D006801:Humans; D008297:Male; D012893:Sleep Wake Disorders / Q000503:physiopathology*
D019382:Human Growth Hormone